Approval · Notice of Compliance 4039 · 1997
SEROQUEL: Notice of Compliance 4039
Issued December 2, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4039
- Date
- December 2, 1997
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antipsychotic
Products in this notice
Medicinal ingredients
- QUETIAPINE FUMARATE 25 MG per TAB
- QUETIAPINE 100 MG per TAB
- QUETIAPINE 200 MG per TAB